You are here

FDA's MedWatch Updates

Viramune (nevirapine) - FDA issued a public health advisory to inform health care providers and patients about recent safety-related changes to the nevirapine (Viramune) label and about appropriate use of HIV triple combination therapy containing nevirapine.
(Posted 01/19/2005)

Methylin CT (Methylphenidate HCl Chewable Tablets) - Recall of one lot due to health risk associated with excess active ingredient in product.
(Posted 01/19/2005)

Aranesp (darbepoetin alfa) - WARNINGS and PRECAUTIONS sections revised to include reports of increased mortality and thrombotic vascular events.
(Posted 01/14/2005)

Source: MedWatch, the FDA Safety Information and Adverse Event Reporting Program

Recent Headlines

Novel Catheter-based Technology for Treating Acute Ischemic Stroke
Decision supported by data from more than 4,000 patients
Triggers the Body’s Own Natural Blood Flow Regulation
Inrebic Reduces Symptoms by 50% in Some Patients
Statistically Significant Improvement in Excessive Daytime Sleepiness
Researcher Made Himself Guinea Pig to Test the Drug
Treatment Shorter, Less Complicated Than Typical Regimen
Zip Device Faster to Apply, Minimizes Scarring